作者: Affectation 時(shí)間: 2025-3-21 21:07
towards the Chakma, the Bru, the Chins/“Burma mi”, and other minorities in the self-declared “.”. The discussion evaluates the questions of Connectivity propelled by the gaze of Act East Policy by construing the policy imaginations and juxtaposing them with rumblings from the fields of implementatio作者: projectile 時(shí)間: 2025-3-22 03:23
Karen P. Phillips M.B.B.S. strategy, or the lack of any determination to do something with particular results anticipated. Politics involves ideology, ideas, and notions of the African reality that writers, publishers, and readers have to deal with in relation to contemporary African literature.作者: intoxicate 時(shí)間: 2025-3-22 06:03 作者: Little 時(shí)間: 2025-3-22 11:16 作者: 心痛 時(shí)間: 2025-3-22 16:14 作者: 整頓 時(shí)間: 2025-3-22 18:18 作者: 正式演說 時(shí)間: 2025-3-22 23:35 作者: nugatory 時(shí)間: 2025-3-23 03:29
Julie A. Humphriesstems for understanding our communities and offer a pathway to genuine African development, i.e., Indigenist African development? (see also Yankah, 2004). How do we speak of Indigenist development mindful of global developments and entanglements around us? Can we afford to pursue development still m作者: cacophony 時(shí)間: 2025-3-23 07:31 作者: 退出可食用 時(shí)間: 2025-3-23 12:56 作者: 不能仁慈 時(shí)間: 2025-3-23 16:39 作者: 刪除 時(shí)間: 2025-3-23 19:13 作者: ellagic-acid 時(shí)間: 2025-3-24 02:16
The Use of Transesophageal Echocardiography to Guide Percutaneous LAA Closurel address how best to assess the LAA with transesophageal echocardiography (TEE) for device closure, how to help your proceduralist get the best results for LAA closure, and recommend procedural imaging protocols which can be used to guide LAA closure.作者: Agnosia 時(shí)間: 2025-3-24 06:15
CT Imaging for Percutaneous LAA Closureool, and is anticipated to overtake TEE as the pre-imaging modality-of-choice for LAA closure. For preplanning imaging, CCTA allows not only anatomic LAA assessment, but also ruling out preexisting thrombus in the LAA that would exclude attempt at LAA closure. In addition, post-surveillance of LAA c作者: 慟哭 時(shí)間: 2025-3-24 10:01
WATCHMAN: Trials and Registries Results 800,000 strokes occur in the U.S., with 1.5 % of these attributed to AF for those under 59 and 23 % of those >80 years of age [3]. Stroke is the third leading cause of death and the number one cause of major morbidity in the U.S. and is estimated to cost the healthcare system ~30 billion dollars an作者: barium-study 時(shí)間: 2025-3-24 11:01
LARIAT: The Endo-Epicardial Technique for Left Atrial Appendage Exclusion WATCHMAN, Amplatzer Cardiac Plug, Coherex Wavecrest) have been developed for use in AF patients who are at increased risk of stroke and also have contraindications to anticoagulation with promising results [9–12]. These devices have been shown to have comparable efficacy to warfarin in preventing t作者: PARA 時(shí)間: 2025-3-24 18:43 作者: Gentry 時(shí)間: 2025-3-24 19:40
Book 2016osure; and current percutaneous approaches and devices available for LAA closure. The emphasis of this book is on percutaneous technical approaches and contemporary trial results on the leading devices (PLAATO, WATCHMAN, Amplatzer Cardiac Plug, and LARIAT). It also reviews unapproved devices in deve作者: 挑剔小責(zé) 時(shí)間: 2025-3-25 00:26
rican development, i.e., Indigenist African development? (see also Yankah, 2004). How do we speak of Indigenist development mindful of global developments and entanglements around us? Can we afford to pursue development still m978-94-6209-659-2作者: lambaste 時(shí)間: 2025-3-25 05:14 作者: dagger 時(shí)間: 2025-3-25 08:33 作者: 懲罰 時(shí)間: 2025-3-25 13:12
Randall J. Lee M.D., Ph.D.rican development, i.e., Indigenist African development? (see also Yankah, 2004). How do we speak of Indigenist development mindful of global developments and entanglements around us? Can we afford to pursue development still m978-94-6209-659-2作者: 試驗(yàn) 時(shí)間: 2025-3-25 19:35
Karen P. Phillips M.B.B.S.,Saibal Kar M.D., F.A.C.C.rican development, i.e., Indigenist African development? (see also Yankah, 2004). How do we speak of Indigenist development mindful of global developments and entanglements around us? Can we afford to pursue development still m978-94-6209-659-2作者: 羅盤 時(shí)間: 2025-3-25 21:41 作者: 阻礙 時(shí)間: 2025-3-26 04:04
Jacqueline Saw MD, FRCPC, FACC, FSCAIrican development, i.e., Indigenist African development? (see also Yankah, 2004). How do we speak of Indigenist development mindful of global developments and entanglements around us? Can we afford to pursue development still m978-94-6209-659-2作者: 不在灌木叢中 時(shí)間: 2025-3-26 05:48 作者: instate 時(shí)間: 2025-3-26 10:51
2196-8969 asis of this book is on percutaneous technical approaches and contemporary trial results on the leading devices (PLAATO, WATCHMAN, Amplatzer Cardiac Plug, and LARIAT). It also reviews unapproved devices in deve978-3-319-35952-6978-3-319-16280-5Series ISSN 2196-8969 Series E-ISSN 2196-8977 作者: Lime石灰 時(shí)間: 2025-3-26 15:47 作者: 詢問 時(shí)間: 2025-3-26 17:53
ACP and Amulet: Trials and Registries Resultsprevention and hemorrhagic risk reduction at long-term follow-up. The Amplatzer Amulet device has been recently released (CE mark since January 2013). Although similar in design, several important modifications have been added to facilitate the implantation process and reduce the number of complications.作者: panorama 時(shí)間: 2025-3-26 21:39
2196-8969 e reduction of thromboembolism in patients with atrial fibriPercutaneous left atrial appendage (LAA) closure is an emerging technology for thromboembolic prevention in patients with atrial fibrillation (AF). The first human implantation of an LAA device occurred in 2001, and since then four devices 作者: gorgeous 時(shí)間: 2025-3-27 03:40
Mechanistic Rationale for LAA Closure with AF and Stroke Preventioneduction of stroke, however, with limited systemic adverse events. This approach has particular attraction to the subgroup of patients at high risk of stroke as well as complications from systemic anticoagulation.作者: venous-leak 時(shí)間: 2025-3-27 08:05
Atrial Fibrillation and Stroke Epidemiologylated stroke is largely preventable. The incidence and prevalence of AF increases substantially with age. Further, a global trend in rising prevalence of AF has been demonstrated in recent decades. The epidemiology of atrial fibrillation and AF-related stroke is reviewed in detail in this chapter.作者: 過去分詞 時(shí)間: 2025-3-27 10:52 作者: Overthrow 時(shí)間: 2025-3-27 17:04
The Use of Intracardiac Echocardiography (ICE) to Guide LAA Closure of the LAA ostium, landing zone, length, shape and number of lobes. It is also helpful to guide the transseptal puncture, sheath placement, device placement, and assess device stability, post-placement leak, and procedural complications [12, 17, 19].作者: DAMP 時(shí)間: 2025-3-27 19:02
LAA Anatomyvertent instrumentation of pulmonary veins and LAA during atrial and transseptal procedures requires a fundamental understanding of the anatomy and spatial relationships of these structures, in order to successfully plan and perform these procedures and avoid significant complications.作者: 表狀態(tài) 時(shí)間: 2025-3-28 00:03
Amplatzer Cardiac Plug and Amulethe third commercial device manufactured specifically for endovascular LAA closure, and real-world experience to-date has shown good safety and clinical efficacy. The second-generation ACP device, Amulet, has just been re-launched. This paper reviews in-depth the device characteristics and procedural techniques of the ACP and Amulet devices.作者: 使苦惱 時(shí)間: 2025-3-28 05:53
Book 2016e first human implantation of an LAA device occurred in 2001, and since then four devices have received CE mark approval. These devices are being widely used in Europe for LAA closure in patients who are poor candidates for long-term oral anticoagulation. In the US, the WATCHMAN device (Boston Scien作者: 發(fā)源 時(shí)間: 2025-3-28 09:00 作者: linear 時(shí)間: 2025-3-28 13:12
Efficacy and Limitations of Warfarin and Novel Oral Anticoagulants with Atrial Fibrillationntithrombotic therapy. Oral anticoagulant therapy (OAC) is extremely effective for the prevention of SSE, and for most patients, the risk:benefit ratio for stroke vs. major hemorrhage favors the use of OAC. A series of randomized controlled trials (RCTs) showed a 64 % reduction in the risk of stroke作者: membrane 時(shí)間: 2025-3-28 15:17
Mechanistic Rationale for LAA Closure with AF and Stroke Preventionnal impairment of the left atrium and left-atrial appendage in combination with specific anatomical characteristics results in altered hemodynamics and a prothrombotic environment. This scenario sets the stage for subsequent systemic and often cerebral emboli. In addition to the well-established app作者: 思考 時(shí)間: 2025-3-28 21:22
LAA Anatomyusion, atrial fibrillation (AF) ablation, mitral valvular repair and replacement, and atrial septal defect closures. Furthermore, intentional and inadvertent instrumentation of pulmonary veins and LAA during atrial and transseptal procedures requires a fundamental understanding of the anatomy and sp作者: Abjure 時(shí)間: 2025-3-28 23:23
Conventional Surgery for LAA Closure of the most serious complications of AF is thromboembolism. The majority of strokes in AF are cardioembolic in nature, with the left atrial appendage (LAA) being the dominant source of emboli. Recent years have had renewed interest in mechanical occlusion of the LAA. This chapter focuses on the sur作者: 不規(guī)則 時(shí)間: 2025-3-29 05:21 作者: 友好 時(shí)間: 2025-3-29 11:00
The Use of Intracardiac Echocardiography (ICE) to Guide LAA ClosureAC therapy [1–18]. The use of imaging techniques is of great importance throughout all phases of the implantation procedure for LAA occlusion, specifically for LAA anatomy evaluation and procedural guidance. Intra-procedural imaging for LAA requires the ability to rule out thrombus, measure the size作者: 落葉劑 時(shí)間: 2025-3-29 14:35 作者: Metamorphosis 時(shí)間: 2025-3-29 16:55 作者: ACRID 時(shí)間: 2025-3-29 22:17 作者: cumber 時(shí)間: 2025-3-30 01:14 作者: slow-wave-sleep 時(shí)間: 2025-3-30 06:09
Amplatzer Cardiac Plug and Amuletover the past two decades. Numerous devices are under clinical investigations and several are already CE-marked. The Amplatzer Cardiac Plug (ACP) is the third commercial device manufactured specifically for endovascular LAA closure, and real-world experience to-date has shown good safety and clinica作者: Calibrate 時(shí)間: 2025-3-30 12:02 作者: 上流社會(huì) 時(shí)間: 2025-3-30 12:43
LARIAT: The Endo-Epicardial Technique for Left Atrial Appendage Exclusionand current projections indicate a prevalence of 6.7 million AF patients in the U.S. in the year 2010 and this is projected to increase to 12.1–15.9 million by the year 2050 [2]. Annual healthcare bill for managing AF patients is estimated to be in the range of $6–$26 billion [3]. Oral anticoagulati作者: 提煉 時(shí)間: 2025-3-30 16:57 作者: FLIT 時(shí)間: 2025-3-30 21:52
